MLKL and metabolic dysfunction-associated steatotic liver disease: Furthermore, in HFD and CD-HFD-induced NAFLD and NASH mouse models, steatohepatitis, liver pathology, liver damage, fibrosis, and apoptosis were all similar between wild-type and MLKL-deficient mice.